These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1061 related articles for article (PubMed ID: 27989061)

  • 1. Predictability and Outcome of Vascular Complications after Transfemoral Transcatheter Aortic Valve Implantation.
    Uguz E; Gokcimen M; Ali S; Alsancak Y; Bastug S; Ahmet Kasapkara H; Canyigit M; Hıdıroglu M; Sener E
    J Heart Valve Dis; 2016 Mar; 25(2):173-181. PubMed ID: 27989061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute and 30-Day Outcomes in Women After TAVR: Results From the WIN-TAVI (Women's INternational Transcatheter Aortic Valve Implantation) Real-World Registry.
    Chieffo A; Petronio AS; Mehilli J; Chandrasekhar J; Sartori S; Lefèvre T; Presbitero P; Capranzano P; Tchetche D; Iadanza A; Sardella G; Van Mieghem NM; Meliga E; Dumonteil N; Fraccaro C; Trabattoni D; Mikhail GW; Sharma S; Ferrer MC; Naber C; Kievit P; Faggioni M; Snyder C; Morice MC; Mehran R;
    JACC Cardiovasc Interv; 2016 Aug; 9(15):1589-600. PubMed ID: 27491609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfemoral aortic valve implantation new criteria to predict vascular complications.
    Hayashida K; Lefèvre T; Chevalier B; Hovasse T; Romano M; Garot P; Mylotte D; Uribe J; Farge A; Donzeau-Gouge P; Bouvier E; Cormier B; Morice MC
    JACC Cardiovasc Interv; 2011 Aug; 4(8):851-8. PubMed ID: 21851897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Iliac Morphology Score Predicts Procedural Mortality and Major Vascular Complications in Transfemoral Aortic Valve Replacement.
    Blakeslee-Carter J; Dexter D; Mahoney P; Ahanchi S; Steerman S; Larion S; Cain B; Panneton JM
    Ann Vasc Surg; 2018 Jan; 46():208-217. PubMed ID: 28689947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfemoral aortic valve implantation is more successful with the Edwards Sapien 3 compared with the Edwards XT for the treatment of symptomatic severe aortic stenosis.
    Gonska B; Seeger J; Junker A; Rodewald C; Trepte U; Scharnbeck D; Rottbauer W; Wöhrle J
    Arch Cardiovasc Dis; 2018; 111(8-9):470-479. PubMed ID: 29128473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative data of single versus double proglide vascular preclose technique after percutaneous transfemoral transcatheter aortic valve implantation from the optimized catheter valvular intervention (OCEAN-TAVI) japanese multicenter registry.
    Kodama A; Yamamoto M; Shimura T; Kagase A; Koyama Y; Tada N; Takagi K; Araki M; Yamanaka F; Shirai S; Watanabe Y; Hayashida K
    Catheter Cardiovasc Interv; 2017 Sep; 90(3):E55-E62. PubMed ID: 27785881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective comparison between three TAVR devices: ACURATE neo vs. CoreValve vs. SAPIEN XT. A single heart team experience in patients with severe aortic stenosis.
    Jatene T; Castro-Filho A; Meneguz-Moreno RA; Siqueira DA; Abizaid AAC; Ramos AIO; Arrais M; Le Bihan DCS; Barretto RBM; Moreira AC; Sousa AGMR; Eduardo Sousa J
    Catheter Cardiovasc Interv; 2017 Jul; 90(1):139-146. PubMed ID: 28029207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of femoral artery puncture using digital subtraction angiography and road mapping on vascular and bleeding complications after transfemoral transcatheter aortic valve implantation.
    El-Mawardy M; Schwarz B; Landt M; Sulimov D; Kebernik J; Allali A; Becker B; Toelg R; Richardt G; Abdel-Wahab M
    EuroIntervention; 2017 Jan; 12(13):1667-1673. PubMed ID: 28106001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1-Year Clinical Outcomes in Women After Transcatheter Aortic Valve Replacement: Results From the First WIN-TAVI Registry.
    Chieffo A; Petronio AS; Mehilli J; Chandrasekhar J; Sartori S; Lefèvre T; Presbitero P; Capranzano P; Tchetche D; Iadanza A; Sardella G; Van Mieghem NM; Meliga E; Dumonteil N; Fraccaro C; Trabattoni D; Mikhail G; Sharma S; Ferrer MC; Naber C; Kievit P; Baber U; Snyder C; Sharma M; Morice MC; Mehran R;
    JACC Cardiovasc Interv; 2018 Jan; 11(1):1-12. PubMed ID: 29301640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcatheter aortic valve implantation in severe calcified annulus using the Lotus valve system: Increased incidence of fatal major vascular complications.
    Conzelmann LO; Würth A; Balthasar V; Neuber C; Tzamalis P; Gonska BD; Schmitt C; Mehlhorn U; Schymik G
    Catheter Cardiovasc Interv; 2020 Jan; 95(1):E21-E29. PubMed ID: 31115146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiographic Analysis of Vascular Integrity After Percutaneous Closure Using Prostar XL Device During Transcatheter Aortic Valve Implantation.
    Lareyre F; Raffort J; Dommerc C; Benhammamia M; Bourlon F; Habib Y; Mialhe C
    Vasc Endovascular Surg; 2017 Jul; 51(5):282-287. PubMed ID: 28474978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular Complications in the Sapien 3 Era: Continued Role of Transapical Approach to Transcatheter Aortic Valve Replacement.
    Toppen W; Suh W; Aksoy O; Benharash P; Bowles C; Shemin RJ; Kwon M
    Semin Thorac Cardiovasc Surg; 2018; 30(2):144-149. PubMed ID: 29522810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transfemoral aortic valve implantation with new-generation devices: the repositionable Lotus vs. the balloon-expandable Edwards Sapien 3 valve.
    Nai Fovino L; Badawy MRA; Fraccaro C; D'Onofrio A; Purita PAM; Frigo AC; Tellaroli P; Mauro A; Tusa M; Napodano M; Gerosa G; Iliceto S; Bedogni F; AbdelRheim AER; Tarantini G
    J Cardiovasc Med (Hagerstown); 2018 Nov; 19(11):655-663. PubMed ID: 30299408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors and incidence of access site complications in transcatheter aortic valve implantation with the use of new delivery systems.
    Sari C; Ayhan H; Aslan AN; Durmaz T; Keleş T; Baştuğ S; Bayram NA; Bilen E; Kasapkara HA; Bozkurt E
    Perfusion; 2015 Nov; 30(8):666-74. PubMed ID: 25795681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Five-year follow-up after transcatheter aortic valve implantation for symptomatic aortic stenosis.
    Zahn R; Werner N; Gerckens U; Linke A; Sievert H; Kahlert P; Hambrecht R; Sack S; Abdel-Wahab M; Hoffmann E; Zeymer U; Schneider S;
    Heart; 2017 Dec; 103(24):1970-1976. PubMed ID: 28684438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sutureless versus Transfemoral Transcatheter Aortic Valve Implant: A Propensity Score Matching Study.
    Santarpino G; Vogt F; Pfeiffer S; Dell'Aquila AM; Jessl J; Cuomo F; von Wardenburg C; Fischlein T; Pauschinger M; Schwab J
    J Heart Valve Dis; 2017 May; 26(3):255-261. PubMed ID: 29092108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular Complications and Bleeding After Transfemoral Transcatheter Aortic Valve Implantation Performed Through Open Surgical Access.
    Leclercq F; Akodad M; Macia JC; Gandet T; Lattuca B; Schmutz L; Gervasoni R; Nogue E; Nagot N; Levy G; Maupas E; Robert G; Targosz F; Vernhet H; Cayla G; Albat B
    Am J Cardiol; 2015 Nov; 116(9):1399-404. PubMed ID: 26414600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Procedural and thirty-day outcomes following transfemoral implantation of the fully repositionable and retrievable Lotus valve without routine pre-dilatation in a consecutive patient cohort: a single-center experience.
    Ruparelia N; Thomas K; Newton JD; Grebenik K; Keiralla A; Krasopoulos G; Sayeed R; Banning AP; Kharbanda RK
    Cardiovasc Revasc Med; 2018; 19(1 Pt B):78-82. PubMed ID: 29137967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome With the Repositionable and Retrievable Boston Scientific Lotus Valve Compared With the Balloon-Expandable Edwards Sapien 3 Valve in Patients Undergoing Transfemoral Aortic Valve Replacement.
    Seeger J; Gonska B; Rottbauer W; Wöhrle J
    Circ Cardiovasc Interv; 2017 Jun; 10(6):. PubMed ID: 28566290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcutaneous aortic valve implantation using the carotid artery access: Feasibility and clinical outcomes.
    Kallinikou Z; Berger A; Ruchat P; Khatchatourov G; Fleisch I; Korkodelovic B; Henchoz E; Marti RA; Cook S; Togni M; Goy JJ
    Arch Cardiovasc Dis; 2017; 110(6-7):389-394. PubMed ID: 28433509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.